New combo aims to extend life in tough lung cancer
NCT ID NCT07418931
First seen Feb 19, 2026 · Last updated May 15, 2026 · Updated 8 times
Summary
This study tests a new combination of the immunotherapy drug cemiplimab plus chemotherapy for people with advanced squamous non-small cell lung cancer who have not had prior treatment. The goal is to see if this approach helps patients live longer. About 108 adults will take part in this open-label phase 2 trial.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED SQUAMOUS NON SMALL CELL LUNG CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
SC Oncologia Azienda Ospedaliera Santa Croce e Carle di Cuneo
Cuneo, CN, 12100, Italy
Contact
-
SC Oncologia Medica Ospedale Carlo Poma, ASST Mantova
Mantua, MN, 46100, Italy
Contact
-
SC Oncologia Medica Provinciale Azienda USL IRCCS di Reggio Emilia
Reggio Emilia, RE, 42123, Italy
Contact
-
SC di Oncologia Azienda Ospedaliera Santa Maria
Terni, TR, 05100, Italy
Contact
-
SOC Oncologia Medica Nuovo Ospedale Santo Stefano
Prato, PO, 59100, Italy
Contact
-
SOD Oncopneumologia Azienda Ospedaliero Universitaria Pisana
Pisa, PI, 56124, Italy
Contact
-
SSD Gruppo di Patologia Toracica IRCCS Istituto Romagnolo per lo Studio dei Tumori "Dino Amadori" - IRST S.r.l.
Meldola, FC, 47014, Italy
Contact
-
UO Oncologia Clinica Azienda Ospedaliero-Universitaria di Ferrara, Arcispedale Sant' Anna
Cona, FE, 44124, Italy
Contact
-
UOC Oncologia Medica ASST Valle Olona - Ospedale di Saronno
Saronno, VA, 21047, Italy
Contact
-
UOC Oncologia Medica Azienda Ospedaliero-Universitaria di Parma
Parma, PR, 43126, Italy
Contact
-
UOC Oncologia Medica IRCCS Azienda Ospedaliero-Universitaria Policlinico Sant'Orsola
Bologna, BO, 40138, Italy
Contact
-
UOC Oncologia Medica Ospedale San Luca
Lucca, LU, 55100, Italy
Contact
-
UOC Oncologia Medica Ospedale Versilia
Lido di Camaiore, LU, 55041, Italy
Contact
-
UOC Oncologia Medica Ospedale dell'Alta Val d'Elsa
Poggibonsi, SI, 53036, Italy
Contact
-
UOC di Oncologia Medica Azienda Ospedaliero Universitaria di Sassari Ospedale Civile SS. Annunziata
Sassari, SS, 07100, Italy
Contact
Conditions
Explore the condition pages connected to this study.